PBAX
Price:
$5.85
Market Cap:
$36.47M
Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe. The company was incorporated in 2021 and is based in Oakland, California.[Read more]
Industry
Shell Companies
IPO Date
2021-11-30
Stock Exchange
NASDAQ
Ticker
PBAX
According to Phoenix Biotech Acquisition Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -16.71. This represents a change of -80.18% compared to the average of -84.34 of the last 4 quarters.
The mean historical PE Ratio of Phoenix Biotech Acquisition Corp. over the last ten years is -498.50. The current -16.71 PE Ratio has changed 235.29% with respect to the historical average. Over the past ten years (40 quarters), PBAX's PE Ratio was at its highest in in the September 2022 quarter at 686.00. The PE Ratio was at its lowest in in the December 2022 quarter at -224.63.
Average
-498.50
Median
-498.50
Minimum
-721.74
Maximum
-275.25
Discovering the peaks and valleys of Phoenix Biotech Acquisition Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = -275.25
Minimum Annual Increase = -61.86%
Minimum Annual PE Ratio = -721.74
Year | PE Ratio | Change |
---|---|---|
2022 | -275.25 | -61.86% |
The current PE Ratio of Phoenix Biotech Acquisition Corp. (PBAX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-498.50
5-year avg
-498.50
10-year avg
-498.50
Phoenix Biotech Acquisition Corp.’s PE Ratio is less than Patria Latin American Opportunity Acquisition Corp. (0), less than Target Global Acquisition I Corp. (7.13), less than Power & Digital Infrastructure Acquisition II Corp. (148.05), greater than Stratim Cloud Acquisition Corp. (-5905.91), less than null (42.43),
Company | PE Ratio | Market cap |
---|---|---|
0 | $137.55M | |
7.13 | $80.91M | |
148.05 | $345.24M | |
-5905.91 | $128.77M | |
42.43 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Phoenix Biotech Acquisition Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Phoenix Biotech Acquisition Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Phoenix Biotech Acquisition Corp.'s PE Ratio?
How is the PE Ratio calculated for Phoenix Biotech Acquisition Corp. (PBAX)?
What is the highest PE Ratio for Phoenix Biotech Acquisition Corp. (PBAX)?
What is the 3-year average PE Ratio for Phoenix Biotech Acquisition Corp. (PBAX)?
What is the 5-year average PE Ratio for Phoenix Biotech Acquisition Corp. (PBAX)?
How does the current PE Ratio for Phoenix Biotech Acquisition Corp. (PBAX) compare to its historical average?